Free Delivery Over $100
|
|
|||
|
||||
OverviewThis volume traces the discovery and development of drugs in Japan and the UK both historically and sociologically. It includes 16 case studies of major pharmaceutical developments in the 20th century, encompassing, amongst others, beta-blockers, beta-stimulants, inhaled steroids and histamine H2-antagonists. Full Product DetailsAuthor: Takuji HaraPublisher: Edward Elgar Publishing Ltd Imprint: Edward Elgar Publishing Ltd Dimensions: Width: 15.60cm , Height: 2.10cm , Length: 23.40cm Weight: 0.566kg ISBN: 9781843760504ISBN 10: 1843760509 Pages: 288 Publication Date: 26 February 2003 Audience: Professional and scholarly , Professional and scholarly , Professional & Vocational , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Active Availability: In Print  This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsContents: 1. Introduction 2. Technological Change and the Pharmaceutical Industry 3. Cardiovascular Drugs 4. Anti-Asthmatic Drugs 5. Histamine H2 Antagonists 6. LHRH Analogues 7. Three Case Studies of Pharmaceutical Innovation in Japan 8. The Process of Drug Discovery and Development 9. Conclusion Bibliography IndexReviews'... this book represents a welcome addition to the small number of works on innovation in the pharmaceutical industry. The case studies give a valuable insight into the innovation process and together with the extensive bibliography will form a valuable aid to researchers specialising in this field.' -- Brian Higginson, R&D Management '... Hara has provided us with a series of extremely important case studies. His research will be appreciated by the many economists, historians, sociologists, and management scholars who are trying to make sense out of the development of the modern pharmaceutical industry and its role in the third industrial revolution of our time.' -- Louis Galambos, Bulletin of the History of Medicine 'It is an innovative book in a variety of ways. Only a small amount of literature of the social studies of technology has dealt with innovation in pharmaceuticals. In part, this is because pharmaceutical companies are naturally wary of allowing outside researchers too close to their innovation processes: it is an information-sensitive business. So one of the great strengths of Hara's book is the access he has achieved. It is also innovative in its consideration of the pharmaceutical industry in Japan, but such is the dearth of material of this kind on pharmaceuticals that even the discussion of the UK cases is largely novel.' -- Donald MacKenzie, University of Edinburgh, UK Author InformationTakuji Hara, Associate Professor, Graduate School of Business Administration, Kobe University, Japan Tab Content 6Author Website:Countries AvailableAll regions |
||||
